Cerebellar tDCS in Children With Autism Spectrum Disorder
Biologic Effects and Efficacy of Cerebellar tDCS in Children With Autism Spectrum Disorder
University of Texas Southwestern Medical Center
60 participants
Jun 4, 2019
INTERVENTIONAL
Conditions
Summary
The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.
Eligibility
Inclusion Criteria4
- -17 years old
- Diagnosed with ASD and ADOS-2
- IQ Score no less than 70 (1.5 Standard Deviations below the mean)
- Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)
Exclusion Criteria5
- Brain implants, metal implants, pacemakers, or biomedical devices
- Diagnosis of epilepsy
- Hearing or visual impairments
- History of brain injury
- Known brain abnormalities not associated with ASD
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A current of 1 mA will be administered for 20 minutes of with either anodal or cathodal tDCS administration to the right crus I/II area of the cerebellum.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04446442